|Agreement labeling||Bioscientifica Journals Read and Publish Transitional Agreement 2023-2024|
|Has the agreement been fully disclosed and published?||Yes|
|Agreement period||01/01/2023 – 12/31/2024|
|Consortia / Institution||Jisc|
Approximate range of annual corresponding author publications
|Comments on size/article output||Average article output 2020-2021|
How do the costs of the agreement relate to previous subscription-only agreements with the publisher?
|Agreement costs within the range of the previous spending level|
|Comments on cost development||Read fees decrease if publish fees increase|
Transfomative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard?
|Subscriptions partly converted to OA publishing fees|
How do entitlements for open access publishing correlate to the anticipated article output? Which mechanisms for risk sharing have been agreed in cases of exceeding or not reaching the number of OA publishing entitlements?
|OA publishing is unlimited for all article types|
Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement?
|Are fully open access journals covered by the agreement?||No|
|OA LICENSE||CC-BY mandatory|
||Original research articles
What is the approximate share of access related costs of the overall agreement?
|More than 50%|
Are all read relevant journals covered by the agreement?
|PERPETUAL ACCESS RIGHTS||Yes|
|WORKFLOW ASSESSMENT||Too early to assess|
|OVERALL ASSESSMENT AND COMMENTS||The agreement covers the publisher’s 5 hybrid titles with unlimited open access publishing for corresponding authors. The fee is fixed for 2 years regardless of output.|
|Request contact to the licensee||contact [at] esac-initiative [dot] org|